• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

髓源性抑制细胞来源的外泌体通过 S100A9/circMID1/miR-506-3p/MID1 促进去势抵抗性前列腺癌的进展。

Exosomes derived from myeloid-derived suppressor cells facilitate castration-resistant prostate cancer progression via S100A9/circMID1/miR-506-3p/MID1.

机构信息

Department of Urology, Hangzhou Hospital of Traditional Chinese Medicine, 453# Tiyuchang Road, Hangzhou, 310007, Zhejiang, China.

Department of Clinical Pharmacology, Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, China.

出版信息

J Transl Med. 2022 Aug 2;20(1):346. doi: 10.1186/s12967-022-03494-5.

DOI:10.1186/s12967-022-03494-5
PMID:35918733
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9344715/
Abstract

BACKGROUND

Castration-resistant prostate cancer (CRPC) is a major cause of recurrence and mortality among prostate cancer (PCa) patients. Myeloid-derived suppressor cells (MDSCs) regulate castration resistance in PCa. Previously, it was shown that intercellular communication was efficiently mediated by exosomes (Exos), but the role and the mechanism of MDSC-derived Exos in CRPC progression was unclear.

METHODS

In this study, the circRNA expression profiles in PC3 cells treated with MDSC-Exo and control cells were investigated using a circRNA microarray.

RESULTS

The data showed that circMID1 (hsa_circ_0007718) expression was elevated in PC3 cells treated with MDSC-Exo. Moreover, high circMID1 expression was found in PCa compared with benign prostatic hyperplasia (BPH) tissues and in CRPC patients compared with hormone sensitive prostate cancer (HSPC) patients. Further studies showed that MDSC-Exo accelerated PCa cell proliferation, migration, and invasion, while circMID1 deficiency inhibited MDSC-Exo-regulated CRPC progression in vitro and in vivo. Mechanistically, MDSC-derived exosomal S100A9 increased circMID1 expression to sponge miR-506-3p, leading to increased MID1 expression and accelerated tumor progression.

CONCLUSION

Together, our results showed that a S100A9/circMID1/miR-506-3p/MID1 axis existed in MDSC-Exo-regulated CRPC progression, which provided novel insights into MDSC-Exo regulatory mechanisms in CRPC progression.

摘要

背景

去势抵抗性前列腺癌(CRPC)是前列腺癌(PCa)患者复发和死亡的主要原因。髓源抑制细胞(MDSCs)调节 PCa 的去势抵抗。先前的研究表明细胞间通讯可被外泌体(Exos)有效地介导,但 MDSC 来源的 Exos 在 CRPC 进展中的作用和机制尚不清楚。

方法

在这项研究中,我们使用 circRNA 微阵列研究了 PC3 细胞用 MDSC-Exo 和对照细胞处理后的 circRNA 表达谱。

结果

数据显示,MDSC-Exo 处理的 PC3 细胞中 circMID1(hsa_circ_0007718)的表达升高。此外,与良性前列腺增生(BPH)组织相比,PCa 中 circMID1 的表达较高,与激素敏感前列腺癌(HSPC)患者相比,CRPC 患者中 circMID1 的表达较高。进一步的研究表明,MDSC-Exo 加速了 PCa 细胞的增殖、迁移和侵袭,而 circMID1 缺乏抑制了 MDSC-Exo 调节的 CRPC 进展。机制上,MDSC 来源的外泌体 S100A9 增加了 circMID1 的表达,以海绵 miR-506-3p,导致 MID1 表达增加并加速肿瘤进展。

结论

总之,我们的结果表明,S100A9/circMID1/miR-506-3p/MID1 轴存在于 MDSC-Exo 调节的 CRPC 进展中,为 MDSC-Exo 在 CRPC 进展中的调节机制提供了新的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0736/9344715/b1ca309a83a7/12967_2022_3494_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0736/9344715/ad8707a1dc9b/12967_2022_3494_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0736/9344715/7a6cd2f91063/12967_2022_3494_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0736/9344715/42ec7c7f4179/12967_2022_3494_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0736/9344715/e7ceb734ec33/12967_2022_3494_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0736/9344715/5c50010a1741/12967_2022_3494_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0736/9344715/d14e8feb2a0c/12967_2022_3494_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0736/9344715/971b8eb4c1e3/12967_2022_3494_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0736/9344715/b1ca309a83a7/12967_2022_3494_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0736/9344715/ad8707a1dc9b/12967_2022_3494_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0736/9344715/7a6cd2f91063/12967_2022_3494_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0736/9344715/42ec7c7f4179/12967_2022_3494_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0736/9344715/e7ceb734ec33/12967_2022_3494_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0736/9344715/5c50010a1741/12967_2022_3494_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0736/9344715/d14e8feb2a0c/12967_2022_3494_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0736/9344715/971b8eb4c1e3/12967_2022_3494_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0736/9344715/b1ca309a83a7/12967_2022_3494_Fig8_HTML.jpg

相似文献

1
Exosomes derived from myeloid-derived suppressor cells facilitate castration-resistant prostate cancer progression via S100A9/circMID1/miR-506-3p/MID1.髓源性抑制细胞来源的外泌体通过 S100A9/circMID1/miR-506-3p/MID1 促进去势抵抗性前列腺癌的进展。
J Transl Med. 2022 Aug 2;20(1):346. doi: 10.1186/s12967-022-03494-5.
2
Circular RNA hsa_circ_0001610 promotes prostate cancer progression by sponging miR-1324 and upregulating PTK6.环状 RNA hsa_circ_0001610 通过海绵吸附 miR-1324 并上调 PTK6 促进前列腺癌进展。
Gene. 2024 Dec 20;930:148818. doi: 10.1016/j.gene.2024.148818. Epub 2024 Aug 2.
3
Circular RNA midline-1 (circMID1) promotes proliferation, migration, invasion and glycolysis in prostate cancer.环状 RNA 中线 1(circMID1)促进前列腺癌的增殖、迁移、侵袭和糖酵解。
Bioengineered. 2022 Mar;13(3):6293-6308. doi: 10.1080/21655979.2022.2037367.
4
Targeting Castration-Resistant Prostate Cancer Using Mesenchymal Stem Cell Exosomes for Therapeutic MicroRNA-let-7c Delivery.靶向间质干细胞外泌体治疗微小 RNA-let-7c 递送来治疗去势抵抗性前列腺癌。
Front Biosci (Landmark Ed). 2022 Sep 6;27(9):256. doi: 10.31083/j.fbl2709256.
5
GR silencing impedes the progression of castration-resistant prostate cancer through the JAG1/NOTCH2 pathway via up-regulation of microRNA-143-3p.GR 沉默通过上调 microRNA-143-3p 抑制 JAG1/NOTCH2 通路从而阻碍去势抵抗性前列腺癌的进展。
Cancer Biomark. 2020;28(4):483-497. doi: 10.3233/CBM-191271.
6
Exosomal circPACRGL promotes progression of colorectal cancer via the miR-142-3p/miR-506-3p- TGF-β1 axis.外泌体 circPACRGL 通过 miR-142-3p/miR-506-3p-TGF-β1 轴促进结直肠癌的进展。
Mol Cancer. 2020 Jul 27;19(1):117. doi: 10.1186/s12943-020-01235-0.
7
Upregulation of miR-3195, miR-3687 and miR-4417 is associated with castration-resistant prostate cancer.miR-3195、miR-3687 和 miR-4417 的上调与去势抵抗性前列腺癌相关。
World J Urol. 2021 Oct;39(10):3789-3797. doi: 10.1007/s00345-021-03723-4. Epub 2021 May 14.
8
miR-21a in exosomes from Lewis lung carcinoma cells accelerates tumor growth through targeting PDCD4 to enhance expansion of myeloid-derived suppressor cells.外泌体中的 miR-21a 通过靶向 PDCD4 促进肿瘤生长,从而增强髓源抑制细胞的扩增。
Oncogene. 2020 Oct;39(40):6354-6369. doi: 10.1038/s41388-020-01406-9. Epub 2020 Aug 27.
9
Exosomal miR-222-3p contributes to castration-resistant prostate cancer by activating mTOR signaling.外泌体 miR-222-3p 通过激活 mTOR 信号通路促进去势抵抗性前列腺癌的发生。
Cancer Sci. 2023 Nov;114(11):4252-4269. doi: 10.1111/cas.15948. Epub 2023 Sep 6.
10
Regulation of NCAPG by miR-99a-3p (passenger strand) inhibits cancer cell aggressiveness and is involved in CRPC.miR-99a-3p(过客链)调控 NCAPG 抑制癌细胞侵袭,参与 CRPC 发生。
Cancer Med. 2018 May;7(5):1988-2002. doi: 10.1002/cam4.1455. Epub 2018 Apr 2.

引用本文的文献

1
The immune landscape of systemic inflammation in prostate cancer.前列腺癌全身炎症的免疫格局。
Cancer Biol Med. 2025 Sep 4;22(8). doi: 10.20892/j.issn.2095-3941.2025.0149.
2
Role of exosomes in castration-resistant prostate cancer.外泌体在去势抵抗性前列腺癌中的作用。
Front Oncol. 2025 May 14;15:1498733. doi: 10.3389/fonc.2025.1498733. eCollection 2025.
3
Exosome-Mediated Chemoresistance in Cancers: Mechanisms, Therapeutic Implications, and Future Directions.外泌体介导的癌症化疗耐药性:机制、治疗意义及未来方向

本文引用的文献

1
Circular RNA midline-1 (circMID1) promotes proliferation, migration, invasion and glycolysis in prostate cancer.环状 RNA 中线 1(circMID1)促进前列腺癌的增殖、迁移、侵袭和糖酵解。
Bioengineered. 2022 Mar;13(3):6293-6308. doi: 10.1080/21655979.2022.2037367.
2
Uncovering the Exosomes Diversity: A Window of Opportunity for Tumor Progression Monitoring.揭示外泌体的多样性:肿瘤进展监测的机遇之窗。
Pharmaceuticals (Basel). 2020 Aug 4;13(8):180. doi: 10.3390/ph13080180.
3
Granulocytic Myeloid-Derived Suppressor Cells Promote the Stemness of Colorectal Cancer Cells through Exosomal S100A9.
Biomolecules. 2025 May 8;15(5):685. doi: 10.3390/biom15050685.
4
Immunomodulatory behavior of CircRNAs in tumor microenvironment.环状RNA在肿瘤微环境中的免疫调节行为
Oncol Res. 2025 Apr 18;33(5):1105-1119. doi: 10.32604/or.2024.054623. eCollection 2025.
5
Therapeutic potential of microRNA-506 in cancer treatment: mechanisms and therapeutic implications.微小RNA-506在癌症治疗中的治疗潜力:作用机制及治疗意义
Front Oncol. 2025 Apr 3;15:1524763. doi: 10.3389/fonc.2025.1524763. eCollection 2025.
6
Small extracellular vesicles: crucial mediators for prostate cancer.小细胞外囊泡:前列腺癌的关键介质
J Nanobiotechnology. 2025 Mar 21;23(1):230. doi: 10.1186/s12951-025-03326-w.
7
Prospect of extracellular vesicles in tumor immunotherapy.细胞外囊泡在肿瘤免疫治疗中的前景。
Front Immunol. 2025 Feb 26;16:1525052. doi: 10.3389/fimmu.2025.1525052. eCollection 2025.
8
Immunoregulatory role of exosomal circRNAs in the tumor microenvironment.外泌体环状RNA在肿瘤微环境中的免疫调节作用
Front Oncol. 2025 Feb 17;15:1453786. doi: 10.3389/fonc.2025.1453786. eCollection 2025.
9
Role of circular RNAs in cancer therapy resistance.环状RNA在癌症治疗耐药中的作用。
Mol Cancer. 2025 Feb 25;24(1):55. doi: 10.1186/s12943-025-02254-5.
10
Prostate Cancer: De-regulated Circular RNAs With Efficacy in Preclinical Models.前列腺癌:在临床前模型中具有疗效的失调环状RNA
Cancer Genomics Proteomics. 2025 Mar-Apr;22(2):136-165. doi: 10.21873/cgp.20494.
粒细胞性髓源性抑制细胞通过外泌体S100A9促进结肠癌细胞的干性。
Adv Sci (Weinh). 2019 Jul 22;6(18):1901278. doi: 10.1002/advs.201901278. eCollection 2019 Sep 18.
4
Circular RNAs add diversity to androgen receptor isoform repertoire in castration-resistant prostate cancer.环状 RNA 为去势抵抗性前列腺癌中的雄激素受体异构体谱增添多样性。
Oncogene. 2019 Nov;38(45):7060-7072. doi: 10.1038/s41388-019-0947-7. Epub 2019 Aug 13.
5
Differential in vivo biodistribution of I-labeled exosomes from diverse cellular origins and its implication for theranostic application.不同细胞来源的 I 标记外体的体内生物分布差异及其在治疗诊断应用中的意义。
Nanomedicine. 2019 Oct;21:102072. doi: 10.1016/j.nano.2019.102072. Epub 2019 Aug 1.
6
Past, present, and future of circRNAs.环状 RNA 的过去、现在和未来。
EMBO J. 2019 Aug 15;38(16):e100836. doi: 10.15252/embj.2018100836. Epub 2019 Jul 25.
7
Circular RNA circABCC4 as the ceRNA of miR-1182 facilitates prostate cancer progression by promoting FOXP4 expression.环状 RNA circABCC4 通过作为 miR-1182 的 ceRNA 促进 FOXP4 表达促进前列腺癌进展。
J Cell Mol Med. 2019 Sep;23(9):6112-6119. doi: 10.1111/jcmm.14477. Epub 2019 Jul 3.
8
Circular RNAs in Cancer: emerging functions in hallmarks, stemness, resistance and roles as potential biomarkers.环状 RNA 在癌症中的作用:在标志物、干性、耐药性方面的新功能及其作为潜在生物标志物的作用。
Mol Cancer. 2019 Apr 18;18(1):90. doi: 10.1186/s12943-019-1002-6.
9
The Landscape of Circular RNA in Cancer.环状 RNA 在癌症中的研究进展
Cell. 2019 Feb 7;176(4):869-881.e13. doi: 10.1016/j.cell.2018.12.021.
10
Human Survival Motor Neuron genes generate a vast repertoire of circular RNAs.人类生存运动神经元基因产生了大量的环状 RNA。
Nucleic Acids Res. 2019 Apr 8;47(6):2884-2905. doi: 10.1093/nar/gkz034.